Journal
BULLETIN OF MATHEMATICAL BIOLOGY
Volume 70, Issue 7, Pages 1994-2016Publisher
SPRINGER
DOI: 10.1007/s11538-008-9336-z
Keywords
chronic myelogenous leukemia; Gleevec; imatinib; mathematical models; agent-based models; difference equations; partial differential equations
Categories
Funding
- American Cancer Society to PPL
- NSF [DMS-0133511]
- PSK
Ask authors/readers for more resources
We derive a model for describing the dynamics of imatinib-treated chronic myelogenous leukemia (CML). This model is a continuous extension of the agent-based CML model of Roeder et al. (Nat. Med. 12(10), 1181-1184, 2006) and of its recent formulation as a system of difference equations (Kim et al. in Bull. Math. Biol. 70(3), 728-744, 2008). The new model is formulated as a system of partial differential equations that describe various stages of differentiation and maturation of normal hematopoietic cells and of leukemic cells. An imatinib treatment is also incorporated into the model. The simulations of the new PDE model are shown to qualitatively agree with the results that were obtained with the discrete-time (difference equation and agent-based) models. At the same time, for a quantitative agreement, it is necessary to adjust the values of certain parameters, such as the rates of imatinib-induced inhibition and degradation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available